
AD Burden on Patients
AD Burden on Patients
Learn more
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.


AD Burden on Patients

.jpg)

Once diagnosed with stage 3 AT1D, patients require lifelong exogenous insulin. This significantly impacts activities of daily living and quality of life, particularly during childhood and adolescence.1-3




